Avrend

Avrend is a biotechnology company focused on the development of Induced Tissue Regeneration (ITR) technologies to treat age-related degenerative diseases. Founded by Dr. Michael D. West, a prominent figure in the fields of telomerase and stem cell biology, the company utilizes cellular reprogramming to reset the epigenetic state of cells to a more youthful and regenerative phenotype. Avrend's research aims to harness the body's innate capacity for repair, potentially reversing the effects of aging in various tissues and organs. The company's platform integrates gene therapy and mRNA delivery systems to precisely control the expression of rejuvenation factors. By targeting the fundamental drivers of cellular aging, Avrend seeks to develop a new class of medicines capable of restoring organ function and extending healthy human lifespan.